期刊文献+

急性心肌梗死患者血清脂蛋白相关磷脂酶A2的表达及其与冠状动脉病变程度和预后的相关性 被引量:33

Expression of lipoprotein-associated phospholipase A2 and its correlation with the severity of coronary lesions and clinical prognosis in patients with acute myocardial infarction
原文传递
导出
摘要 目的:研究急性心肌梗死(AMI)患者血清脂蛋白相关磷脂酶A2(Lp-PLA2)的表达及其与冠状动脉(冠脉)病变程度及预后的关系。方法:选取2017-06-2018-10于西安交通大学第一附属医院心内科就诊的740例AMI患者为研究对象,依据患者检测的Lp-PLA2水平的中位数180 pg/ml为切点,分为Lp-PLA2升高组(316例)和Lp-PLA2正常组(424例)。采用ELISA法测定血浆Lp-PLA2浓度,采用Gensini评分评估冠脉病变程度。比较2组患者资料,分析Lp-PLA2水平与临床指标的相关性。随访12个月,比较2组心血管不良事件的发生率。结果:Lp-PLA2升高组白细胞计数(WBC)、中性粒细胞百分比(NEUT)、心肌肌钙蛋白T(cTnT)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、D-二聚体、高敏C反应蛋白(hs-CRP)、冠脉病变支数、Gensini积分、多支病变等指标水平均高于Lp-PLA2正常组,组间比较差异有统计学意义(均P<0.05)。Spearman相关分析显示,Lp-PLA2水平与Gensini积分、hs-CRP、LDL-C和D-二聚体呈正相关性(r=0.187、0.196、0.323、0.075,均P<0.05)。进一步多因素分析显示,TC(OR:0.442,95%CI:0.256~0.694,P<0.05)、LDL-C(OR:5.656,95%CI:2.944~10.868,P<0.05)、hs-CRP(OR:1.127,95%CI:1.082~1.174,P<0.05)、D-二聚体(OR:1.310,95%CI:1.075~1.596,P<0.05)是Lp-PLA2表达的相关因素。Lp-PLA2升高组12个月心血管不良事件发生率为18.35%(62/316),高于Lp-PLA2正常组的12.50%(59/424),差异具有统计学意义(P<0.05)。结论:AMI患者Lp-PLA2水平与LDL-C、hs-CRP及D-二聚体相关,与冠脉病变程度及预后有密切的相关性。 Objective:To investigate the expression of plasma lipoprotein-associated phospholipase A2(Lp-PLA2)and its correlation with the severity of coronary lesions and clinical prognosis in patients with acute myocardial infarction(AMI).Method:A total of 740 AMI patients were enrolled and divided into a high expression group(n=316)and a normal expression group(n=424)according to the median expression level of plasma Lp-PLA2(180 pg/ml).The plasma Lp-PLA2 concentration was measured by the ELISA test,and the degree of coroany artery disease was calculated by the Gensini score.Clinical data were collected and compared;the relationship between Lp-PLA2 and clinic indexes was analyzed.All patients were followed up for 12 months to compare the incidence of cardiovascular adverse events between the two groups.Result:The levels of WBC,NEUT,cTnT,TC,LDL-C,D-dimer,hs-CRP,number of coronary lesions,Gensini score,and the number of multivessel coronary artery lesions in high expression group were greater than those in normal expression group(all P<0.05).Spearman correlation analysis showed that Lp-PLA2 was positively correlated with Gensini score,hs-CRP,LDL-C and D-dimer(r=0.187,0.196,0.323,0.075,all P<0.05).Multivariate Logistic regression analysis showed that TC(OR:0.442,95%CI:0.256-0.694,P<0.05),LDL-C(OR:5.656,95%CI:2.944-10.868,P<0.05),hs-CRP(OR:1.127,95%CI:1.082-1.174,P<0.05),D-dimer(OR:1.310,95%CI:1.075-1.596,P<0.05)were related factors of Lp-PLA2.The incidence of cardiovascular adverse events during a 12-month follow-up in the high expression group was higher than that in the normal expression group(18.35%vs.12.50%,P<0.05).Conclusion:The expression of Lp-PLA2 is correlated with LDL-C,hs-CRP and D-dimer,and closely related to the degree of coronary lesions and prognosis in patients with AMI.
作者 余航 陈慧 曹丽菲 王萍 田刚 YU Hang;CHEN Hui;CAO Lifei;WANG Ping;TIAN Gang(Department of Cardiology,First Affiliated Hospital of Xi’an jiaotong University,Xian,710061,China)
出处 《临床心血管病杂志》 CAS 北大核心 2020年第5期433-437,共5页 Journal of Clinical Cardiology
基金 国家自然科学基金项目(No:81873513,81600574,30871042) 陕西省科学技术研究发展计划重点项目(No:2018ZDXM-SF-049) 陕西省科学技术研究发展计划自然科学基础研究计划项目(No:2014 JM2-8145) 陕西省科学技术研究发展计划国际科技合作与交流计划项目(No:2012 kw-40-01) 西安交通大学第一附属医院临床研究重点项目(No:XJTU1AF-CRF-2018-005)。
关键词 急性心肌梗死 脂蛋白相关磷脂酶A2 冠状动脉病变程度 acute myocardial infarction lipoprotein associated phospholipase A2 severity of coronary lesion
  • 相关文献

参考文献4

二级参考文献48

  • 1刘甲兴,郑兴,秦永文,丁继军,赵仙先,曹江.脂蛋白相关性磷脂酶A_2活性能反映冠状动脉粥样硬化病变程度[J].第二军医大学学报,2006,27(4):391-395. 被引量:31
  • 2Sachdeva A, Cannon CP, Deedwania PC, et al. Lipid levels in patients hospitalized with coronary artery disease: An analysis of 136,905 hospitalizations in Get With The Guidelines [ J ]. Am Heart J, 2009, 157(1) : 111-117.
  • 3Packard CJ, O' Reilly DS, Caslake MJ, et al. Lipoprotein- associated phospholipase A2 as an independent predictor of coronary heart disease [ J ]. N Engl J Med, 2000, 343 ( 16 ) : 1148-1155.
  • 4Maephee CH. Lipoprotein-associated phospholipase A2 : a potential new risk factor for coronary artery disease and a therapeutic target [ J 1. Curr Opin Phamacol, 2001, 1 (2) : 121- 125.
  • 5Six DA, Dennis EA. The expanding superfamily of phospholipase A (2) enzymes : classification and characterization [ J 1. Biochim Biophys Acta, 2000, 1488(1-2) : 1-19.
  • 6Tew DG, Southan C, Rice SQ, et al. Purification, properties, sequencing, and cloning of a lipoprotein-assoeiated, serine- dependent phospholipase involved in the oxidative modification of low-density lipoproteins [ J ]. Arterioscler Thromb Vasc Biol, 1996, 16(4) : 591-599.
  • 7Tsimikas S, Tsironis LD, Tselepis AD. New insights into the role of lipoprotein (a) -associated lipoprotein-associated phospholipase A2 in atheroselerosis and cardiovascular disease [ J ]. Arterioscler Thromb Vasc Biol, 2007, 27(10): 2094-2099.
  • 8Blake GJ, Dada N, Fox JC, et al. A Prospective Evaluation of Lipoprotein-Associated Phospholipase A2 Levels and the Risk of Future Cardiovascular Events in Women [ J ]. J Am Coil Cardiol, 2001, 38(5) : 1302-1306.
  • 9Btilakis ES, Khera A, McGuire DK, et al. Influence of race and on lipoprotein-associated phospholipase A2 levels : Observations from the Dallas Heart Study [ J]. Atherosclerosis, 2008, 199(1): 110-115.
  • 10Albert MA, Glynn R J, Wolfert RL, et al. The effect of statintherapy on lipoprotein associated phospholipase A2 levels [ J ]. Atherosclerosis, 2005, 182( 1 ) : 193-198.

共引文献45

同被引文献318

引证文献33

二级引证文献128

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部